Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manabu Morimoto

Showing results (101-110 of 160) with videos related to

Pageof 16
Sort By:
Anticancer Research|April 30, 2016
The Surgical Apgar Score Is an Independent Prognostic Factor in Patients with Pancreatic Cancer Undergoing Pancreatoduodenectomy Followed by Adjuvant ChemotherapyToru Aoyama, Keisuke Kazama, Masaaki Murakawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[Safety and Feasibility of the Bioabsorbable Staple Line Reinforcement in Distal Pancreatic Resections]Toru Aoyama, Masaaki Murakawa, Koichiro Yamaoku, et al.
In Vivo (Athens, Greece)|December 29, 2019
Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective StudyMasaaki Murakawa, Naoto Yamamoto, Yuto Kamioka, et al.
Liver Cancer|May 14, 2020
Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with LenvatinibHaruki Uojima, Makoto Chuma, Yoshiaki Tanaka, et al.
Journal of Cancer Research and Therapeutics|December 13, 2018
Survival and the prognosticators of peritoneal cytology-positive pancreatic cancer patients undergoing curative resection followed by adjuvant chemotherapyToru Aoyama, Yosuke Atsumi, Keisuke Kazama, et al.
Cancer Science|August 12, 2021
Tissue factor and its procoagulant activity on cancer-associated thromboembolism in pancreatic cancerSatoshi Kobayashi, Shiro Koizume, Tomoko Takahashi, et al.
Gastrointestinal Endoscopy|April 30, 2013
Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasmsRyonho Koh, Kingo Hirasawa, Sei Yahara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 8, 2014
Field practice study of half-dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysisManabu Morimoto, Kazushi Numata, Masaaki Kondo, et al.
Diagnostics (Basel, Switzerland)|May 13, 2026
Vascular Features of Gallbladder Lesions Using Microvascular Flow Imaging on Transabdominal Ultrasonography: A Retrospective StudyHaruo Miwa, Ritsuko Oishi, Nene Sakai, et al.
Oncology Letters|May 20, 2017
Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabineToru Aoyama, Yohei Miyagi, Masaaki Murakawa, et al.
Pageof 16

Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
Anticancer Research|April 30, 2016
The Surgical Apgar Score Is an Independent Prognostic Factor in Patients with Pancreatic Cancer Undergoing Pancreatoduodenectomy Followed by Adjuvant ChemotherapyToru Aoyama, Keisuke Kazama, Masaaki Murakawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[Safety and Feasibility of the Bioabsorbable Staple Line Reinforcement in Distal Pancreatic Resections]Toru Aoyama, Masaaki Murakawa, Koichiro Yamaoku, et al.
In Vivo (Athens, Greece)|December 29, 2019
Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective StudyMasaaki Murakawa, Naoto Yamamoto, Yuto Kamioka, et al.
Liver Cancer|May 14, 2020
Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with LenvatinibHaruki Uojima, Makoto Chuma, Yoshiaki Tanaka, et al.
Journal of Cancer Research and Therapeutics|December 13, 2018
Survival and the prognosticators of peritoneal cytology-positive pancreatic cancer patients undergoing curative resection followed by adjuvant chemotherapyToru Aoyama, Yosuke Atsumi, Keisuke Kazama, et al.
Cancer Science|August 12, 2021
Tissue factor and its procoagulant activity on cancer-associated thromboembolism in pancreatic cancerSatoshi Kobayashi, Shiro Koizume, Tomoko Takahashi, et al.
Gastrointestinal Endoscopy|April 30, 2013
Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasmsRyonho Koh, Kingo Hirasawa, Sei Yahara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 8, 2014
Field practice study of half-dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysisManabu Morimoto, Kazushi Numata, Masaaki Kondo, et al.
Diagnostics (Basel, Switzerland)|May 13, 2026
Vascular Features of Gallbladder Lesions Using Microvascular Flow Imaging on Transabdominal Ultrasonography: A Retrospective StudyHaruo Miwa, Ritsuko Oishi, Nene Sakai, et al.
Oncology Letters|May 20, 2017
Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabineToru Aoyama, Yohei Miyagi, Masaaki Murakawa, et al.
Pageof 16